Correction: CS MEDICA A/S: CEO, Lone Henriksen, buys shares in the Company

CS MEDICA A/S posted earlier today a press release informing that that CEO, Lone Henriksen has acquired in total of 7.610 shares in CS MEDICA at an average price of DKK 4,16, amounting to a total value of 31.628,35 DKK. The press release was erroneously marketed as MAR.

CEO of CS MEDICA, Lone Henriksen, has purchased 7.610 shares in the open market at an average price of DKK 4,16 per share, corresponding to a total purchase of 31.628,35 DKK. Following the transaction, Lone Henriksen owns 4.174.180 CS MEDICA shares.

For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@cs-medica.com
Website: https://www.cs-medica.com/

CS MEDICA, a Danish MedTech pioneer, specializes in developing evidence-based, CBD-integrated treatments for pain management, autoimmune and stress-related disorders. With a focus on patient-centric care, our products range from innovative R&D to registered over-the-counter substance-based medical devices and dermaceuticals. Our flagship CANNASEN® brand, alongside our own-label solutions, exemplifies our dedication to safe, high-quality treatments for both human and veterinary health globally.

The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information, visit cs-medica.com and LinkedIn.